Multiple Electrolytes Injection (II) and Normal Saline on Hyperchloremia in Severe Hemorrhagic Stroke

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

342

Participants

Timeline

Start Date

May 31, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Critical CareHyperchloremiaHemorrhagic Stroke
Interventions
DRUG

Multiple Electrolyte

Patients who are randomized to multiple electrolyte group will be receiving Multiple Electrolytes injection II for 72 hours continously after inrollment as maintence and rescutation fluids. Infusion speed and volume will be determained by physicians.

DRUG

Normal Saline

Patients who are randomized to normal saline group will be receiving Sodium Chloride injection for 72 hours continously after inrollment as maintence and rescutation fluids. Infusion speed and volume will be determained by physicians.

Trial Locations (1)

100038

Beijing Shijitan Hospital, Beijing

All Listed Sponsors
lead

Capital Medical University

OTHER

NCT06374823 - Multiple Electrolytes Injection (II) and Normal Saline on Hyperchloremia in Severe Hemorrhagic Stroke | Biotech Hunter | Biotech Hunter